Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma
- 1 September 2008
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 135 (3), 947-955.e5
- https://doi.org/10.1053/j.gastro.2008.05.046
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Heterogeneity in androgen receptor levels and growth response to dihydrotestosterone in sublines derived from human hepatocellular carcinoma line (KYN-1)Liver International, 2008
- Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X proteinVirology, 2007
- NF-κB functions as a tumour promoter in inflammation-associated cancerNature, 2004
- Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinomaBiochemical and Biophysical Research Communications, 2004
- Abnormal Mammary Gland Development and Growth Retardation in Female Mice and MCF7 Breast Cancer Cells Lacking Androgen ReceptorThe Journal of Experimental Medicine, 2003
- A Recycling Pathway for Resecretion of Internalized Apolipoprotein E in Liver CellsPublished by Elsevier BV ,2001
- Sex steroid metabolism and receptor status in hepatic hyperplasia and cancer in ratsGastroenterology, 1996
- Sex-steroid receptors in the diethylnitrosamine model of hepatocarcinogenesis: modifications by gonadal ablation and steroid replacement therapyJournal of Molecular Endocrinology, 1989
- Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5α-dihydrotestosteroneEuropean Journal of Cancer and Clinical Oncology, 1987
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979